Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cervical cancer
Closed
Phase 2
This trial is comparing having tiragolumab and atezolizumab with atezolizumab on its own for cervical cancer that has come back or spread.
Recruitment start: 28 September 2020
Recruitment end: 10 February 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mary McCormack
Roche
Last reviewed: 1 March 2021
CRUK internal database number: 17221